Idenix Tanks as Hep C Drug is Put on Hold; TG Inks Pact Worth $250M - Aug. 16, 2012

Having trouble viewing this email? View in Browser.

Thursday, August 16, 2012  |   |   |   |  Join us for a Complimentary Luncheon: Thursday, August 23rd from 1:00-1:30 at the Next Generation Dx Summit in Boston A Blood-Based Protein Biomarker Approach to Companion Diagnostic Development • Choosing the right patients - disease segmentation in heterogeneous diseases • Case study of a successful program: CDx diagnostic partnership with Pharma • Myriad RBM partnership models: flexibility, shared risk, and strategic fit Please click here for more information.   •  Idenix Pharmaceuticals, Inc. (IDIX) Tanks as Hep C Drug is Put on Hold More... •  TG Therapeutics, Inc. Inks Pact Worth $250 Million More... •  Biogen Idec, Inc. (Massachusetts) (BIIB), Regulus Therapeutics, Inc. Cut Deal to Monitor MS More... •  Novartis AG (NVS) Eye Drug Shows Promise in Study More... •  Pfizer Inc. (PFE)'s Experimental Drug Works in Ulcerative Colitis More... •  FDA: Codeine Can be Fatal to Some Children More... •  IMPAX Laboratories, Inc. (IPXL) Hopes Parkinson's Drug is a Game Changer More... •  Abbott Laboratories (ABT) Paid CEO More Than Taxes to Uncle Sam More... More Top News Choose a CRO Partner Who Understands Your Unique Development World. Whether you're investigating an apparatus, instrument, machine or other type of device, our Medical Device Business Unit knows your success hinges upon highly specialized regulatory, reimbursement programs, safety and marketing support. Operating on high-quality systems, we can prepare those key documents that will ultimately clear your product for marketplace entry. Even after your commercial launch, we're here to help propel your device to that next level. From developing a reimbursement strategy to meeting post-marketing surveillance requirements, we offer the added value of a long-term relationship that endures throughout every phase of your device's lifecycle. Visit Theorem to Find Out More. •  Dark Chocolate May Help Lower Blood Pressure, National Institute of Integrative Medicine Study More... •  New Drug Extends Life in Men With Advanced Prostate Cancer Patients, Memorial Sloan-Kettering Cancer Center Study More... •  Genetic Material in Blood Cells May Affect Malaria Parasites, Duke University Medical Center Study More... •  Babies May Not Have a "Moral Compass" After All, University of Otago Study More... •  "CYCLOPS" Genes May Serve as an Achilles' Heel in Tumor Cells, Dana-Farber Cancer Institute and Broad Institute Study More... •  Gut Bacteria Linked to Obesity and Metabolic Syndrome Identified, University of Maryland School of Medicine Study More... •  New Technology Could Improve Treatment for Diabetes, Other Disorders, Texas A&M University Study More... •  Walnuts May Improve Sperm Health, University of California, Los Angeles (UCLA) Study More...   More Featured News The 6th Annual Pain Therapeutics October 3 - 4, 2012 San Francisco, CA Event Website ARROWHEAD'S ANNUAL PAIN THERAPEUTICS SUMMIT is the US's premier conference covering the field of pain management and therapeutics. Leaders from the pharmaceutical, biotech, device and medical communities attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, the non-profit sector, academia, the medical community, government and investors. This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA's REMS program and a plethora of other topics. Please click here for more information. • BioMidwest (Indianapolis, Indiana) Otsuka America Pharmaceutical, Inc. Manager - IT Enterprise Information Management Services Will provide technical leadership and direct a team to support the implementation, governance, processes and technical approaches for service oriented architecture and enterprise application integration in a manner that ensures high quality outcomes, customer satisfaction and cost effectiveness. • Pharm Country (Berkeley Height, New Jersey) Celgene Senior Manager, Case Management Coordinate the preparation of key periodic safety reports for Celgene's development products. Manage periodic literature review for safety data relevant to development products. • Biotech Beach (San Diego, California) Sequenom Inc. Quality Document Control Supervisor Responsible for managing the Company's quality management systems for documentation control, learning management, and record retention. This position will maintain and oversee the Change Control process including Change Orders affecting new product development and post-market design changes, maintenance of the Company's quality records, and management of the training system. • Biotech Bay (Hayward, California) MedImmune, LLC Scientist II/Senior Scientist Initiate, develop and implement analytical methods/new technology at bench and critically review data for internal and external publication (tech reports and manuscripts). Design, execute assay qualification and validation. • BioForest (Seattle, Washington) Amgen Director Preclinical Will provide strategic vision and portfolio leadership in support of small and large molecule drug development, registration, and/or post-marketing activities. He/she will be responsible for portfolio-level strategic and resource planning, communication, scientific/technical deliverables, and issue resolution. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! 2012 Pharm Country Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the tri-state area. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Pharm Country Career Fair, Bridgewater, NJ September 13, 2012 • Biotech Beach Career Fair, San Diego, CA September 20, 2012 • Biotech Bay Career Fair, Burlingame, CA October 3, 2012 • BioCapital Career Fair, Bethesda, MD October 9, 2012 • BioMidwest Career Fair, Lincolnshire, IL October 22, 2012 • Bio NC Career Fair, Durham, NC October 25, 2012 • Genetown Career Fair, Cambridge, MA November 5, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Strategies to Enhance API Manufacturing Processes • Enhance profitability by re-evaluating and re-engineering product development, manufacturing technologies, and commercialization methodologies. • Evaluate ways to simplify manufacturing technologies and implement sustainable processes. • Identify examples where process enhancements have had a substantial impact on yield and profitability. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! Operon Biotechnologies, Inc. 2211 Seminole Drive Huntsville, Alabama 35805 U.S.A. Phone: 800-688-2248 Operon Biotechnologies, Inc. is the global market leader in high throughout synthesis and provider of a wide range of quality DNA oligonucleotides, array-ready oligo sets (AROS™) and preprinted slides (OpARRAY™). Driven by incomparable customer service and reliable delivery, Operon employs advanced synthesis technologies and support. More Company Profiles FREE Subscription to Chain Drug Review Chain Drug Review has firmly established itself as the premier source for timely industry news and in-depth product category analyses. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.